文献速递甲状腺疾病

碘酪氨酸是Dehal1基因敲除小鼠碘缺乏性甲状腺功能减退临床前阶段的生物标志物

Iodotyrosines Are Biomarkers for Preclinical Stages of Iodine-Deficient Hypothyroidism in Dehal1-Knockout Mice.
PubMed 文献 · Thyroid · 2023-04-19

研究通过基因捕获构建Dehal1敲除小鼠,用X-Gal染色和免疫荧光定位Dehal1表达,并给予正常或限碘饮食1个月,用液相色谱-串联质谱法和Sandell-Kolthoff法监测甲状腺功能及碘酪氨酸。结果显示Dehal1敲除小鼠在甲状腺功能正常时已出现尿和血浆碘酪氨酸持续升高,限碘后迅速发生严重甲状腺功能减退,提示碘酪氨酸可预测临床前阶段的碘缺乏和甲状腺功能减退。

要点

  • Dehal1在甲状腺高表达,也见于肾、肝和脉络丛,限碘仅诱导甲状腺内Dehal1转录。
  • 正常碘摄入下Dehal1敲除小鼠甲状腺功能正常,但尿碘酪氨酸持续丢失致碘负平衡。
  • Dehal1敲除小鼠尿碘浓度是野生型的两倍,提示Sandell-Kolthoff法同时测定无机碘和有机碘。

核心结论

  • Dehal1缺陷小鼠终生存在血浆和尿碘酪氨酸升高,测定碘酪氨酸可预测临床前阶段的碘缺乏和甲状腺功能减退的发生。
  • 限碘后Dehal1敲除小鼠迅速发生严重甲状腺功能减退,而野生型小鼠保持甲状腺功能正常,提示其甲状腺碘储备低、储碘能力缺陷。

研究设计与样本

  • 通过基因捕获构建Dehal1敲除小鼠,用X-Gal染色和免疫荧光研究胎儿和成年小鼠中重组Dehal1-β-半乳糖苷酶蛋白的表达时相与分布。
  • 成年Dehal1敲除小鼠和野生型小鼠分别给予正常饮食和限碘饮食1个月,分离血浆、尿液和组织进行分析。
  • 用新型液相色谱-串联质谱法和Sandell-Kolthoff技术监测甲状腺功能状态,包括甲状腺素、三碘甲状腺原氨酸、MIT、DIT和尿碘浓度。

主要发现

  • Dehal1在甲状腺高表达,也存在于肾脏、肝脏以及出乎意料地存在于脉络丛。
  • 仅在甲状腺组织中,限碘诱导Dehal1的体内转录。
  • 正常碘摄入下Dehal1敲除小鼠甲状腺功能正常,但因尿中碘酪氨酸持续丢失而呈碘负平衡。
  • Dehal1敲除小鼠的尿碘浓度是野生型小鼠的两倍,提示Sandell-Kolthoff法同时测定无机碘和有机碘。
  • 限碘后Dehal1敲除小鼠迅速发生严重甲状腺功能减退,而野生型小鼠保持甲状腺功能正常,提示Dehal1敲除小鼠甲状腺碘潴留减少。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Iodine is required for the synthesis of thyroid hormone (TH), but its natural availability is limited. Dehalogenase1 (Dehal1) recycles iodine from mono- and diiodotyrosines (MIT, DIT) to sustain TH synthesis when iodine supplies are scarce, but its role in the dynamics of storage and conservation of iodine is unknown. Methods: Dehal1-knockout (Dehal1KO) mice were generated by gene trapping. The timing of expression and distribution was investigated by X-Gal staining and immunofluorescence using recombinant Dehal1-beta-galactosidase protein produced in fetuses and adult mice. Adult Dehal1KO and wild-type (Wt) animals were fed normal and iodine-deficient diets for 1 month, and plasma, urine, and tissues were isolated for analyses. TH status was monitored, including thyroxine, triiodothyronine, MIT, DIT, and urinary iodine concentration (UIC) using a novel liquid chromatography with tandem mass spectrometry method and the Sandell-Kolthoff (S-K) technique throughout the experimental period. Results: Dehal1 is highly expressed in the thyroid and is also present in the kidneys, liver, and, unexpectedly, the choroid plexus. In vivo transcription of Dehal1 was induced by iodine deficiency only in the thyroid tissue. Under normal iodine intake, Dehal1KO mice were euthyroid, but they showed negative iodine balance due to a continuous loss of iodotyrosines in the urine. Counterintuitively, the UIC of Dehal1KO mice is twofold higher than that of Wt mice, indicating that S-K measures both inorganic and organic iodine. Under iodine restriction, Dehal1KO mice rapidly develop profound hypothyroidism, while Wt mice remain euthyroid, suggesting reduced retention of iodine in the thyroids of Dehal1KO mice. Urinary and plasma iodotyrosines were continually elevated throughout the life cycles of Dehal1KO mice, including the neonatal period, when pups were still euthyroid. Conclusions: Plasma and urine iodotyrosine elevation occurs in Dehal1-deficient mice throughout life. Therefore, measurement of iodotyrosines predicts an eventual iodine shortage and development of hypothyroidism in the preclinical phase. The prompt establishment of hypothyroidism upon the start of iodine restriction suggests that Dehal1KO mice have low iodine reserves in their thyroid glands, pointing to defective capacity for iodine storage.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. González-Guerrero C, Borsò M, Alikhani P, et al. Iodotyrosines Are Biomarkers for Preclinical Stages of Iodine-Deficient Hypothyroidism in Dehal1-Knockout Mice. Thyroid. 2023. PMID: 36879468. doi:10.1089/thy.2022.0537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。